Gennova Biopharmaceuticals Granted Conditional Permission for Human Clinical Trial of Its COVID-19 Vaccine

December 9, 2020

The recommendations of the Subject Expert Committee on COVID-19, which deliberated upon the proposal submitted by the firm for grant of permission to conduct phases 1 and 2 clinical trials along with animal toxicity study data, has been approved by DCGI.

Previous articleCan’t disclose details of PM’s flights as it relates to his security apparatus, IAF tells Delhi HC

Next articleBJP Leader, Former Maharashtra Minister Vishnu Savara Dead

Gennova Biopharmaceuticals Granted Conditional Permission for Human Clinical Trial of Its COVID-19 Vaccine

Similar Articles

Most Popular

Gennova Biopharmaceuticals Granted Conditional Permission for Human Clinical Trial of Its COVID-19 Vaccine

Similar Articles

Lakhimpur Kheri: Viral Video Shows Farmers Being Run Over by SUV, Oppn Questions Union Minister’s Claims

Karnataka: 3 Dead After Drinking Contaminated Water, 108 Show Similar Symptoms

Most Popular

AMPC reforms: BJP digs out Siddaramaiah’s old letter

India UAE Grow Bilateral Trade Amidst Worldwide Geopolitical Shifts

Author Amish on why Bollywood doesn’t adapt ancient Sanskritic texts into films